Since Meridia was first approved as a weight loss pill, Public Citizen has been trying to get it banned. The public advocacy group has petitioned the FDA multiple times to withdrawal the diet drug due to serious heart risks.
Abbott Laboratories finally issued a Meridia recall Oct. 8, 2010 after a request from the FDA. The diet pill has been used by numerous patients and has been linked to more than a 15 percent increased risk of both fatal and non-fatal cardiac problems.
Public Citizen says the recall took too long. Its first petition to the FDA was in 2002. Since then, more than 3 million people have been prescribed Meridia for obesity. The group re-petitioned a Meridia diet drug ban in 2009. Since then approximately 160,000 prescriptions have been filled in the U.S.
Despite the FDA's approval,
there have been hundreds of serious Meridia
side effects reported to the FDA, including
29 deaths. Prior to approval, when asked if
the benefits of sibutramine outweighed the risks,
the FDA's Endocrinologic and Metabolic Drugs
Advisory Committee voted 5 to 4 against
Meridia's approval. Since 1996, the Health
Research Group of Public Citizen has petitioned
for the removal of four other drugs previously
approved by the FDA. Three of the drugs are
now banned, and the fourth is severely restricted. Public Citizen finds Meridia to be both ineffective
and unsafe.
View the entire Public Citizen petition.
Click
Here...
|
|
On May 22, 2001, the consumer
advocacy group Public Citizen called on the
US government to bring criminal charges against
Abbott Laboratories, the manufacturers of Meridia
for allegedly withholding information about
adverse events and 8 patient deaths related
to Meridia. These allegations are based on
an FDA inspection of an Abbott plant in Illinois
conducted in late March and early April.
View the entire Public Citizen letter. Click
Here...
Every year, an estimated 300,000
Americans die from obesity-related illnesses
costing the United States an estimated $117
billion annually. With insurers increasingly
willing to pay for preventative treatments,
pharmaceutical companies are under increasing
pressure to develop a new miracle weight-loss
drug, which could potentially generate an enormous
profit.
Abbott Laboratories disputes
the validity of the FDA's statistics that link
patient deaths to Meridia, and also argues that
obese people are already at risk for heart problems
and high blood pressure. Abbott maintains that
Meridia is an effective weight loss treatment
in obese patients, is safe when used as indicated,
and has strong support throughout the world.
Spokespersons for Abbott have
also stated that possible side effects are clearly
listed for doctors and patients.
To read Abbott Laboratories'
entire Press Release regarding Meridia weight
loss pill, Click
Here...
|